These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 22729844)
1. A facile three- and four-component procedure toward the synthesis of functionalized pyrano- and benzo[f]quinoxaline derivatives. Ghadari R; Hajishaabanha F; Aghaei M; Shaabani A; Ng SW Mol Divers; 2012 Aug; 16(3):453-61. PubMed ID: 22729844 [TBL] [Abstract][Full Text] [Related]
2. Highly efficient synthesis of quinoxaline derivatives from 1,2-benzenediamine and α-aminoxylated 1,3-dicarbonyl compounds. Yan J; Xu Y; Zhuang F; Tian J; Zhang G Mol Divers; 2016 May; 20(2):567-73. PubMed ID: 26797715 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of [1,2,5]chalcogenazolo[3,4-f]benzo[1,2,3]triazole and [1,2,3]triazolo[3,4-g]quinoxaline derivatives. Tam TL; Li H; Lam YM; Mhaisalkar SG; Grimsdale AC Org Lett; 2011 Sep; 13(17):4612-5. PubMed ID: 21812401 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of highly functionalized polycyclic quinoxaline derivatives using visible-light photoredox catalysis. He Z; Bae M; Wu J; Jamison TF Angew Chem Int Ed Engl; 2014 Dec; 53(52):14451-5. PubMed ID: 25347967 [TBL] [Abstract][Full Text] [Related]
5. Green and efficient synthesis of quinoxaline derivatives via ceric ammonium nitrate promoted and in situ aerobic oxidation of alpha-hydroxy ketones and alpha-keto oximes in aqueous media. Shaabani A; Maleki A Chem Pharm Bull (Tokyo); 2008 Jan; 56(1):79-81. PubMed ID: 18175980 [TBL] [Abstract][Full Text] [Related]
6. A green approach toward quinoxalines and bis-quinoxalines and their biological evaluation against A431, human skin cancer cell lines. Bandyopadhyay D; Cruz J; Morales LD; Arman HD; Cuate E; Lee YS; Banik BK; Kim DJ Future Med Chem; 2013 Aug; 5(12):1377-90. PubMed ID: 23919549 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents. Primas N; Suzanne P; Verhaeghe P; Hutter S; Kieffer C; Laget M; Cohen A; Broggi J; Lancelot JC; Lesnard A; Dallemagne P; Rathelot P; Rault S; Vanelle P; Azas N Eur J Med Chem; 2014 Aug; 83():26-35. PubMed ID: 24946216 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives. Hajri M; Esteve MA; Khoumeri O; Abderrahim R; Terme T; Montana M; Vanelle P Eur J Med Chem; 2016 Nov; 124():959-966. PubMed ID: 27770736 [TBL] [Abstract][Full Text] [Related]
9. Microwave-assisted solvent-dependent reaction: chemoselective synthesis of quinoxalin-2(1H)-ones, benzo[d]imidazoles and dipeptides. Wang SL; Ding J; Jiang B; Gao Y; Tu SJ ACS Comb Sci; 2011 Sep; 13(5):572-7. PubMed ID: 21815688 [TBL] [Abstract][Full Text] [Related]
10. Characterization of 2-phenylbenzo[g]quinoxaline derivatives as viscosity-sensitive fluorescent probes. Wang K; Shi W; Jia J; Chen S; Ma H Talanta; 2009 Mar; 77(5):1795-9. PubMed ID: 19159801 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the structure of (E)-2-(2-benzylidenehydrazinylidene)quinoxaline with those of its chloro- and bromobenzylidene analogues. Gomes LR; Low JN; Rodrigues AS; Wardell JL; de Souza MV; Noguiera TC; Pinheiro AC Acta Crystallogr C; 2013 Aug; 69(Pt 8):920-6. PubMed ID: 23907890 [TBL] [Abstract][Full Text] [Related]
12. Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity. El Newahie AM; Ismail NS; Abou El Ella DA; Abouzid KA Arch Pharm (Weinheim); 2016 May; 349(5):309-26. PubMed ID: 27062086 [TBL] [Abstract][Full Text] [Related]
13. Novel Synthetic Routes to Prepare Biologically Active Quinoxalines and Their Derivatives: A Synthetic Review for the Last Two Decades. Khatoon H; Abdulmalek E Molecules; 2021 Feb; 26(4):. PubMed ID: 33670436 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, leptospirocidal activity and QSAR analysis of novel quinoxaline derivatives. Puratchikody A; Natarajan R; Doble M; Iswarya SH; Vijayabharathi R Med Chem; 2013 Mar; 9(2):275-86. PubMed ID: 22779788 [TBL] [Abstract][Full Text] [Related]
15. From simple quinoxalines to potent oxazolo[5,4-f]quinoxaline inhibitors of glycogen-synthase kinase 3 (GSK3). Lassagne F; Duguépéroux C; Roca C; Perez C; Martinez A; Baratte B; Robert T; Ruchaud S; Bach S; Erb W; Roisnel T; Mongin F Org Biomol Chem; 2019 Dec; 18(1):154-162. PubMed ID: 31803883 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents. Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395 [TBL] [Abstract][Full Text] [Related]
17. Nucleophilic Substitution on 2-Monosubstituted Quinoxalines Giving 2,3-Disubstituted Quinoxalines: Investigating the Effect of the 2-Substituent. Ndlovu NT; Nxumalo W Molecules; 2016 Sep; 21(10):. PubMed ID: 27706058 [TBL] [Abstract][Full Text] [Related]
18. One-pot synthesis of pyrrolo[1,2-a]quinoxaline derivatives via iron-promoted aryl nitro reduction and aerobic oxidation of alcohols. Pereira Mde F; Thiéry V Org Lett; 2012 Sep; 14(18):4754-7. PubMed ID: 22971137 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives. Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818 [TBL] [Abstract][Full Text] [Related]
20. The synthesis and optical properties of fluorescent quinoxalines and of electrospun fibers containing fluorescent quinoxaline. Jang CK; Jaung JY J Nanosci Nanotechnol; 2011 Jan; 11(1):494-8. PubMed ID: 21446483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]